Hualan Biological Engineering (SZSE:002007) Construction In Progress : ¥725 Mil (As of Mar. 2024)

View and export this data going back to 2004. Start your Free Trial

What is Hualan Biological Engineering Construction In Progress?

Hualan Biological Engineering's quarterly construction in progress increased from Sep. 2023 (¥417 Mil) to Dec. 2023 (¥662 Mil) and increased from Dec. 2023 (¥662 Mil) to Mar. 2024 (¥725 Mil).

Hualan Biological Engineering's annual construction in progress increased from Dec. 2021 (¥133 Mil) to Dec. 2022 (¥216 Mil) and increased from Dec. 2022 (¥216 Mil) to Dec. 2023 (¥662 Mil).

Hualan Biological Engineering Construction In Progress Historical Data

The historical data trend for Hualan Biological Engineering's Construction In Progress can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Hualan Biological Engineering Construction In Progress Chart

Hualan Biological Engineering Annual Data

Trend

Dec14

Dec15

Dec16

Dec17

Dec18

Dec19

Dec20

Dec21

Dec22

Dec23

Construction In Progress

Get a 7-Day Free Trial

109.81

379.44

132.96

216.39

661.51

Hualan Biological Engineering Quarterly Data
	Jun19	Sep19	Dec19	Mar20	Jun20	Sep20	Dec20	Mar21	Jun21	Sep21	Dec21	Mar22	Jun22	Sep22	Dec22	Mar23	Jun23	Sep23	Dec23	Mar24
Construction In Progress	Get a 7-Day Free Trial															243.57	242.98	416.80	661.51	724.92

Hualan Biological Engineering Construction In Progress Calculation

It records the cost of construction work, which is not yet completed (typically, applied to capital budget items). A construction in progress item is not depreciated until the asset is placed in service. Normally, upon completion, a construction in progress item is reclassified, and the reclassified asset is capitalized and depreciated.

Hualan Biological Engineering (SZSE:002007) Business Description

Industry

GURUFOCUS.COM » STOCK LIST » Healthcare » Biotechnology » Hualan Biological Engineering Inc (SZSE:002007) » Definitions » Construction In Progress

Traded in Other Exchanges

N/A

Address

No. A1 Hualan Avenue, Henan Province, Xinxiang, CHN, 453003

Website

http://www.hualanbio.com

Hualan Biological Engineering Inc is a China-based biopharmaceutical company. It is engaged in the research, development, production, and commercialization of plasma products, viral vaccines, bacterial vaccines, and recombinant proteins and other biologics. The plasma products offered by the company include Human albumin, Human fibrinogen, Human tetanus immunoglobulin and others. The vaccines products include Recombinant hepatitis B vaccine, Inactivated influenza vaccine and other. It also offers gene products such as Monoclonal Antibody for tumor, autoimmune diseases, infectious diseases, transplant rejection, and Recombinant monoclonal antibodies.

Executives

An Kang	Directors, executives
Pan Ruo Wen	Executives
An Wen Qi	Executives
Wang Qi Ping	Directors, executives
Fan Bei	Directors, executives
Ma Xiao Wei	Executives
Xie Jun Min	Directors, executives
Zhang Bao Xian	Executives
Lv Cheng Yu	Securities Affairs Representative
Zhang Jin Gang	Independent director
Wang Li Ting	Independent director
Ma Li	Supervisors
Sun Zhen Guo	Supervisors
Chen Lei Shan	Supervisors
Yang Bao Ping	Supervisors

Hualan Biological Engineering (SZSE:002007) Headlines

No Headlines